Location History:
- Hertfordshire, GB (2009 - 2012)
- Radlett, GB (1998 - 2015)
Company Filing History:
9 out of 850 
2 out of 34 
1 out of 35 Years Active: 1998-2015
Title: The Innovative Contributions of S Tarran Jones
Introduction
S Tarran Jones, an inventor based in Radlett, GB, has made significant contributions to the field of biotechnology, particularly through his innovative work involving humanized antibodies. With a remarkable portfolio of 12 patents, Jones stands out as a leading figure in the world of medical innovation, focusing on therapeutic methodologies.
Latest Patents
Among his recent patents, Jones's work titled "Humanized anti-CCR2 antibodies and methods of use therefor" is particularly noteworthy. This invention pertains to humanized antibodies or functional fragments that bind to the human CC-chemokine receptor 2 (CCR2), effectively blocking the interaction of ligands with the receptor. Furthermore, the patent details methods for using these antibodies in therapeutic, prophylactic, and diagnostic applications, showcasing his commitment to advancing healthcare solutions.
Career Highlights
Throughout his career, S Tarran Jones has worked with distinguished companies that bolster his innovative endeavors. Notably, he has been affiliated with Millennium Pharmaceuticals Limited and Cytel Corporation, where he contributed his expertise in biotherapeutics and drug development. His extensive experience in these organizations has significantly influenced his research trajectory and patent accomplishments.
Collaborations
Jones's journey in innovation is complemented by his collaborations with renowned professionals in the field. Notable coworkers include Walter Newman and Gregory J LaRosa, who have shared in the pursuit of groundbreaking discoveries and therapeutic advancements. These collaborations have enhanced the impact of his inventions and reaffirmed the importance of teamwork in scientific research.
Conclusion
In summary, S Tarran Jones is a prolific inventor whose work has the potential to transform the landscape of therapeutic interventions. His latest patents, particularly in the area of humanized antibodies, highlight his role in pioneering medical research. With a strong foundation built on corporate experience and collaborative efforts, Jones continues to push the boundaries of innovation in biotechnology.